Transparent method for protecting fine structure of tissue and application thereof

By incubating biological tissues by using transparent reagents prepared by solvents, urea, sorbitol and iodhelol, the biological tissues were solved, and the biological tissue structure damage and fluorescent label loss caused by transparency in the prior art was solved, and the biological tissues were realized. Fast lossless transparency and fluorescence-friendly, suitable for a variety of biological tissues and labeling methods, improving the microscope imaging effect.

CN118883218APending Publication Date: 2024-11-01ZHEJIANG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411040307.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-01

AI Technical Summary

Technical Problem

The existing tissue transparency technology reduces the attenuation of light by biological tissues, while destroying the fine structure and fluorescent marking of biological tissues, making it difficult to take into account the transparency effect and fluorescence protection capabilities, limiting its in-fields such as medical diagnosis and neuroscience. application.

Method used

Using a transparent reagent prepared from solvent, urea, sorbitol and iodhelol, biological tissue sections are incubated, combined with specific labeling and fixation treatment, to ensure optical transparency and fluorescence-friendliness of the tissue, suitable for two-photons and confocal transparent imaging.

Benefits of technology

It realizes rapid lossless optical transparency of biological tissues, retains the fine structure of biological tissues, is compatible with commonly used immunohistochemical markers and fluorescent markers, improves the depth of microscope imaging and the clarity of fluorescent images, and is suitable for a variety of biological tissues and labeling methods. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118883218A_ABST
    Figure CN118883218A_ABST
Patent Text Reader

Abstract

The invention discloses a transparentizing method for protecting a fine structure of a tissue and application of the transparentizing method. The method comprises the following steps: fixing and separating a biological tissue, slicing to obtain a biological tissue slice, marking, soaking in a transparent reagent prepared only from a solvent, urea, sorbitol and iohexol, incubating, sealing the incubated biological tissue slice, and drying to obtain the biological tissue slice. And finally, transparent imaging which does not influence the mark and the biological tissue structure is carried out. The method can be applied to two-photon and confocal transparent imaging of biological tissues, reagents used in the method are simple in component and low in cost, reagent soaking only needs one step, and the method is simple, easy to implement and wide in applicability; the transparentizing reagent used in the method can be used for performing fluorescence-friendly rapid transparentizing and labeling imaging on the biological tissue while keeping the fine structure of the biological tissue, is suitable for various common immunohistochemical labeling and fluorescence labeling, and has no influence on autofluorescence imaging of the transgenic animal tissue.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a tissue transparency method, relates to the field of biological sample processing and biomedical imaging, and specifically relates to a transparency method for protecting fine tissue structure and application thereof. Background Art

[0002] Tissue clearing is the use of one or several special chemical reagents (clearing agents) to treat biological tissues or organs to reduce the attenuation of light by the tissue, thereby making the biological tissue optically transparent and convenient for optical imaging observation of the tissue. The principle is to reduce the light scattering and light absorption of biological tissues, and to reduce the absorption and scattering of light through various chemical or physical methods, so that the light beam can propagate deeper into the substance, thereby greatly improving the imaging depth of the microscope. It has been increasingly widely used in the fields of neuroscience, tumor systems, and three-dimensional pathology detection. However, most of the existing tissue clearing technologies rely on defatting treatment, which will cause the loss of the original lipid information of the biological tissue (such as the destruction of the cell membrane), and will also destroy the fine structure inside the biological tissue. At the same time, it is difficult for existing transparent technologies to take into account both transparent effects and compatibility and fluorescence protection capabilities. This limits the application of tissue clearing technology in medical diagnosis, neuroscience, immunology and other fields. Summary of the invention

[0003] In order to solve the problems in the background technology, the present invention provides a transparent method for protecting the fine structure of tissue and its application. The present invention can quickly and non-destructively make biological tissue optically transparent, and is compatible with various commonly used immunohistochemical markers (such as hematoxylin-eosin staining (HE), Nissl staining, periodic acid-Schiff staining (PAS), Masson staining (Masson)) and fluorescent markers (immunological markers, lipophilic dye markers, virus markers).

[0004] The technical solution adopted by the present invention is:

[0005] 1. A transparent method to protect the delicate structure of tissues:

[0006] 1) Fixing and separating biological tissues and then slicing them to obtain biological tissue slices of a certain thickness.

[0007] 2) After the biological tissue sections are labeled, they are immersed in a clearing agent prepared only from a solvent, urea, sorbitol and iohexol for incubation.

[0008] 3) Seal the incubated biological tissue sections.

[0009] 4) The sealed biological tissue sections are transparently imaged without affecting the labeling and biological tissue structure.

[0010] In the step 1), the thickness of the biological tissue slices ranges from 0 to 1000 μm, and preferably the thickness of the biological tissue slices ranges from 0 to 400 μm.

[0011] In the step 1), the biological tissue is brain, heart, lung tissue, spleen, liver or kidney; the biological tissue is derived from reptiles, birds or mammals.

[0012] In the step 2), the mass volume ratio of urea to solvent is 350g-800g:1L, the mass volume ratio of sorbitol to solvent is 200g-500g:1L, and the mass volume ratio of iohexol to solvent is 200g-550g:1L.

[0013] In the step 2), the solvent in the transparentizing agent is a mixed solution of dimethyl sulfoxide and water; the volume ratio of dimethyl sulfoxide to water is 1:0.5-1.5.

[0014] In the step 2), before the biological tissue slices are immersed, the biological tissue slices are specifically labeled, and the specific labeling includes but is not limited to immunofluorescence labeling, dye labeling, histopathological staining and virus labeling. The biological tissue slices with specific labeling and tissue processing requirements are specifically labeled and tissue processed, such as removing calcium components from biological tissue slices containing bones, and performing corresponding fixation treatments on tissues of different biological tissue slices.

[0015] In the step 2), when the biological tissue slices are immersed in the transparentizing agent for incubation, the temperature is kept at 20° C. to 40° C. and the shaking speed is kept at 20 rpm / min to 80 rpm / min.

[0016] When the thickness of the biological tissue section is 0-300μm, the soaking time is less than 10min; when the thickness of the biological tissue section is 300μm-500μm, the soaking time is less than 1h; when the thickness of the biological tissue section is 500μm-1000μm, the soaking time is more than 30min.

[0017] In the step 4), imaging is performed using an electron microscope or an optical microscope, including a transmission electron microscope, a wide-field fluorescence microscope, a laser sheet scanning microscope, a laser confocal microscope, and a two-photon fluorescence microscope.

[0018] 2. A transparentizing agent for transparent imaging:

[0019] The transparentizing agent for transparent imaging is prepared by the transparentizing method described above.

[0020] 3. Application of a transparent reagent for transparent imaging:

[0021] Applications described include use in two-photon and confocal clearing imaging.

[0022] The present invention discloses a fluorescence-friendly transparency method and application suitable for various commonly used immunohistochemical markers and fluorescent markers. The present invention utilizes tissue light transparency technology to greatly simplify the tissue sample transparency treatment process, and quickly achieves transparency of thicker tissues. The tissue light transparency technology can reduce the scattering and absorption of light by biological tissues by removing lipids, water, pigments, etc. inside biological tissues, thereby increasing the imaging depth of optical microscopes and clearly presenting fluorescent images of deep tissues. At the same time, the present invention can retain the fine structure of biological tissues and is fluorescence-friendly, which is beneficial to the transparency and imaging effects of biological tissue sections with specific labeling, tissue immunofluorescence labeling, immunohistochemical labeling, dye labeling, HE staining, etc.

[0023] The beneficial effects of the present invention are:

[0024] 1. The method of the present invention can be applied to two-photon and confocal clearing imaging of biological tissues.

[0025] 2. The transparent reagent used in the method of the present invention has simple ingredients and low cost. The reagent soaking only requires one step, which is simple and easy to operate and has wide applicability.

[0026] 3. The transparentizing agent used in the method of the present invention is prepared only from solvent, urea, sorbitol and iohexol, so that after the biological tissue is immersed, the biological tissue can be rapidly transparentized and labeled for imaging in a fluorescence-friendly manner while retaining the fine structure of the biological tissue.

[0027] 4. The method of the present invention is applicable to various commonly used immunohistochemical markers and fluorescent markers, and has no effect on the imaging of autofluorescence of transgenic animal tissues. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 This is a comparison diagram of the non-transparentized 300um brain slice and the transparentized 300um brain slice in Example 1, wherein: Figure 1 (a) is a schematic diagram of a 300 um brain slice before transparentization in Example 1, Figure 1 (b) is a schematic diagram of a 300 μm brain slice after transparent treatment in Example 1;

[0029] Figure 2 This is a comparison of the electron microscopy results of the non-transparentized 300um brain slice and the transparentized 300um brain slice in Example 1, wherein: Figure 1 (a) is a schematic diagram of the electron microscopy results of a 300 μm brain slice before transparent treatment in Example 1, Figure 1(b) is a schematic diagram of the electron microscopy results of a 300 μm brain slice after transparent treatment in Example 1;

[0030] Figure 3 The results of imaging the transgenic mouse brain slices at different times after being transparent in Example 2 are shown in FIG. Figure 3 (a) is the imaging result of the transgenic mouse brain slice at day 0 after transparency in Example 2, Figure 3 (b) is the imaging result of the transgenic mouse brain slice 7 days after being transparent in Example 2. Figure 3 (c) is the imaging result of the transgenic mouse brain slice 10 days after being transparent in Example 2. Figure 3 (d) is the imaging result of the transgenic mouse brain slice 30 days after being transparent in Example 2;

[0031] Figure 4 This is a graph showing the change in normalized fluorescence intensity of transgenic mouse brain slices at different times after being transparent in Example 2;

[0032] Figure 5 The imaging results of mouse brain slices labeled with DiI dye at different times after being transparent in Example 3 are shown, wherein: Figure 5 (a) is the imaging result of the mouse brain slice labeled with DiI dye at 0 days after transparency in Example 3, Figure 5 (b) is the imaging result of the mouse brain slice labeled with DiI dye 4 days after transparency in Example 3, Figure 5 (c) is the imaging result of the mouse brain slice labeled with DiI dye 10 days after transparency in Example 3, Figure 5 (d) is the imaging result of the mouse brain slice labeled with DiI dye 30 days after transparency in Example 3;

[0033] Figure 6 The graph is a normalized fluorescence intensity change curve of mouse brain slices labeled with DiI dye at different times after being transparent in Example 3;

[0034] Figure 7 This is an imaging result diagram of the compatibility of various labeling methods in Example 4, wherein: Figure 7 (a) is the imaging result diagram of the compatibility of the labeling method in Example 4. Figure 7 (a) is an imaging result diagram of the compatibility of the DAPI labeling method in Example 4, Figure 7 (b) is an imaging result diagram of the compatibility of the PI labeling method in Example 4, Figure 7 (c) is an imaging result diagram of the compatibility of the SYTO labeling method in Example 4, Figure 7 (d) is the imaging result diagram of the compatibility of the TO-PRO-3 marking method in Example 4, Figure 7 (e) is an imaging result diagram of the compatibility of the CD31 labeling method in Example 4, Figure 7 (f) is the imaging result diagram of the compatibility of the GFAP labeling method in Example 4, Figure 7 (g) is an imaging result diagram of the compatibility of the NeuN labeling method in Example 4, Figure 7 (h) is an imaging result diagram of the compatibility of TH labeling methods in Example 4;

[0035] Figure 8 The imaging results of four pathological stainings in the mouse brain slice in Example 5 are shown in FIG. Figure 8 (a) is the imaging result of the control group of four pathological stainings in the mouse brain slice in Example 5, Figure 8 (b) is the imaging result diagram of the test group of four pathological stainings in the mouse brain slice in Example 5. DETAILED DESCRIPTION

[0036] The present invention is further described in detail below with reference to the accompanying drawings and specific embodiments.

[0037] The specific embodiments and comparative examples of the present invention are as follows:

[0038] Embodiment 1:

[0039] The transparent method for protecting the fine structure of tissue of the present invention is used to make mouse brain slices transparent and image them with an electron microscope. The specific steps are as follows:

[0040] 1) 8-week-old adult mice were anesthetized with 1% pentobarbital, the chest cavity was opened, 50 ml of phosphate buffer saline (PBS) was perfused through the heart at a flow rate of 38 rpm / min to flush the blood, and then 30 ml of 4% paraformaldehyde (PFA) solution was perfused through the heart at a flow rate of 38 rpm / min for fixation. The head was then cut to remove the brain, and the mouse brain tissue was placed in a 2 ml polybutene BP tube containing 4% PFA solution and placed in a refrigerator at 4°C overnight, and then the brain tissue was removed and sliced ​​using an oscillating microtome to obtain mouse brain slices with a thickness of 300 μm.

[0041] 2) 20 g urea, 25 g sorbitol, 23.8 g iodine, 30 ml water and 20 ml dimethyl sulfoxide were mixed evenly to obtain 100 ml of a transparent reagent that can protect the fine structure of tissues and is fluorescence-friendly.

[0042] 3) The obtained mouse brain slices were placed in a 24-well plate, and after adding a clearing agent, they were immersed and incubated at a constant temperature of 30° C. and an oscillation speed of 50 rpm / min for 15 minutes, and the mouse brain slices after clearing treatment were photographed.

[0043] 4) Rinse the transparent mouse brain slices with 1 ml of 0.1M PBS solution for 3 times, 10 min each time; then add 50-100 u1 (covering the mouse brain slices) of 1% osmium acid to fix for 1.5 hours; then rinse with 1 ml of ultrapure water for 3 times, 10 min each time; then treat with 100 u1 of 2% uranyl acetate for 30 min; then add 1 ml of 50%, 70%, and 90% ethanol in turn for 15 min each time, then add 1 ml of 100% ethanol for 20 min, and then add 1 ml of 100% acetone twice, each time for 20 minutes; next, add 400ul of a mixture of embedding agent and acetone in a volume ratio of 1:1 and put it in a drying oven for 2 hours; then add 400ul of a mixture of embedding agent and acetone in a volume ratio of 3:1 and put it in a drying oven overnight; then add pure embedding agent for penetration, and after the mouse brain slices are solidified, first stain them with lead citrate stain for 10 minutes, and wash them with decarbonated double distilled water for 3 times; then stain them with uranyl acetate stain for 30 minutes, and wash them with double distilled water for 3 times; after the mouse brain slices are dry, observe them using a transmission electron microscope.

[0044] like Figure 1 (a) and Figure 1 As shown in (b), it shows the comparison of the 300um mouse brain slice before and after transparentization in Example 1. It can be seen that the method of the present invention can quickly transparentize and label the biological tissue while retaining the fine structure of the biological tissue.

[0045] Comparative Example 1:

[0046] Electron microscopic imaging of the mouse brain slices that were not transparentized was performed only after step 1) and step 4) in Example 1.

[0047] like Figure 2 (a) and Figure 2 As shown in (b), the transmission electron microscopy results of the 300um mouse brain slice that was not transparentized in the comparative example and the 300um mouse brain slice that was transparentized in Example 1 are compared. It can be seen that after the biological tissue is treated with a transparentizing agent that retains fine structure, the membrane structure therein is not destroyed, and the results similar to the membrane structure of the biological tissue that is not treated with a transparentizing agent can be obtained. The black arrow indicates the membrane structure.

[0048] Embodiment 2:

[0049] Transgenic mouse brain slices were transparentized and imaged using a clearing method that preserves tissue fine structures. The specific steps are as follows:

[0050] 1) 8-week-old adult Thy-1 driven yellow fluorescent protein transgenic mice (Thy1-YFP-H) were anesthetized with 1% pentobar, and the brain was harvested by perfusion in the same manner as in Example 1. For transgenic mouse tissue, the obtained biological tissue was protected from light, and a transgenic mouse brain slice with a thickness of 300 μm was obtained by slicing with an oscillating microtome.

[0051] 2) 30 g urea, 22 g sorbitol, 20 g iodine, 25 ml water and 23 ml dimethyl sulfoxide were mixed evenly to obtain 100 ml of a transparent reagent that can retain fine structures and is fluorescence-friendly.

[0052] 3) The obtained transgenic mouse brain slices were placed in a 24-well plate, and after adding a clearing agent, they were immersed and incubated at a constant temperature of 30° C. and an oscillation speed of 50 rpm / min for 15 minutes.

[0053] 4) Use glue to stick a 300 μm gasket on the slide, place the treated transgenic mouse brain slice in the center of the gasket, add 2-3 drops of sealing agent so that the liquid can fully fill the space in the center of the gasket, and cover with a cover glass for sealing.

[0054] 5) Fluorescence imaging of the brain slices of transgenic mice was performed on days 0, 7, 10, and 30 after transparency, and the normalized fluorescence intensity was measured and the curve was drawn using the image processing and analysis software ImageJ.

[0055] like Figure 3 (a) Figure 3 (b) Figure 3 (c) and Figure 3 As shown in (d), the fluorescence retention imaging results of the transgenic mouse brain slices at different time points after transparency in Example 2 are shown. Figure 4 As shown, the normalized fluorescence intensity change curve of the transgenic mouse brain slices at different time points after transparentization in Example 2 is shown. It can be seen from the figure that the fluorescence intensity of the transgenic mouse brain slices at 7 days, 10 days, and 30 days after transparentization always remains at a high level, indicating that the transparentizing reagent used is fluorescence-friendly and suitable for fluorescence-labeled tissue observation.

[0056] Embodiment 3:

[0057] The mouse brain slices labeled with the cell membrane orange-red fluorescent probe DiI dye were transparentized and imaged using a transparent method that protects the fine structure of the tissue. The specific steps are as follows:

[0058] 1) Dissolve 3 mg of DiI in 1 mL of anhydrous ethanol to prepare a DiI dye stock solution. Mix 10 mL of 0.01 M PBS solution and 40 mL of 5% (w / v) glucose aqueous solution, then add 1 mL of the DiI dye stock solution and mix well to obtain a DiI working solution.

[0059] 2) 8-week-old adult transgenic mice were anesthetized with 1% pentobarbital, the chest cavity was opened, 50 ml of PBS solution was perfused through the heart at a flow rate of 38 rpm / min to flush the blood, and then 50 ml of DiI working solution was perfused through the heart at a flow rate of 5 rpm / min, and then 30 ml of 4% PFA solution was perfused through the heart at a flow rate of 38 rpm / min for fixation. The head was then cut to remove the brain, and the mouse brain tissue was placed in a 2 ml BP tube filled with 4% PFA solution, wrapped with tin foil to avoid light, and placed in a 4°C refrigerator overnight, and the brain tissue was removed and sliced ​​using an oscillating microtome to obtain a mouse brain slice with a thickness of 300 μm.

[0060] 3) 30 g urea, 22 g sorbitol, 20 g iodine, 25 ml water and 23 ml dimethyl sulfoxide were mixed evenly to obtain 100 ml of a transparent reagent that can retain fine structures and is fluorescence-friendly.

[0061] 4) The obtained mouse brain slices were placed in a 24-well plate, and after adding a clearing agent, they were immersed and incubated at a constant temperature of 30° C. and an oscillation speed of 50 rpm / min for 15 minutes.

[0062] 5) Use glue to stick a 300 μm gasket on the slide, place the treated mouse brain slice in the center of the gasket, add 2-3 drops of sealing agent so that the liquid can fully fill the space in the center of the gasket, and cover with a cover glass for sealing.

[0063] 6) Fluorescence imaging of mouse brain slices was performed at 0 days, 4 days, 10 days, and 30 days after transparency, and the normalized fluorescence intensity of neurons was measured using the image processing and analysis software ImageJ, and a curve was drawn based on the change in normalized fluorescence intensity.

[0064] like Figure 5 (a) Figure 5 (b) Figure 5 (c) and Figure 5 As shown in (d), the fluorescence retention imaging results of mouse brain slices labeled with DiI dye at different time points after transparency in Example 3 are shown. Figure 6 As shown, the fluorescence intensity change curve of the mouse brain slice labeled with DiI dye at different time points after transparentization in Example 3 is shown. It can be seen from the figure that the fluorescence intensity of the mouse brain slice labeled with DiI dye at 10 days and 30 days after transparentization decreases slightly but is always at a high level, indicating that the transparentizing reagent used is fluorescence-friendly and suitable for DiI dye-labeled tissue observation.

[0065] Embodiment 4:

[0066] The compatibility of various commonly used fluorescent labeling methods was explored and imaged using a transparent method that protects the fine structure of the tissue. The specific steps are as follows:

[0067] 1) Sample preparation: The biological tissue sampling procedure was the same as that in Example 1. After obtaining the mouse brain tissue, an oscillating microtome was used to slice the mouse brain slices to obtain a thickness of 150 μm, which were divided into two groups: an immunofluorescence staining group and a dye staining group.

[0068] 2) Reagent preparation: ① Blocking solution: add 100 μl Triton X-100 and 3 ml donkey serum into 97 ml PBS solution and mix evenly; ② Buffer solution: add 200 μl Triton X-100, 3 ml donkey serum and 3 ml dimethyl sulfoxide (DMSO) into 94 ml PBS solution and mix evenly; ③ Clearing reagent: mix 25 g urea, 20 g sorbitol, 20 g iohexol, 25 ml water and 20 ml dimethyl sulfoxide to obtain 100 ml of clearing reagent that can retain fine structure and is fluorescence-friendly.

[0069] 3) Immunofluorescence staining group: The obtained mouse brain slices were placed in a 24-well plate, 1-2 ml of blocking solution was added and incubated for 6 hours, and then the corresponding first antibodies were added to the buffer solution, the volume ratio of the first antibody to the buffer solution was 1:300, and the first antibody incubation solution was obtained after mixing evenly. The mouse brain slices were transferred to the first antibody incubation solution, and placed on a shaker at 37°C and shaken at 50 rpm / min for 3 days, and then the mouse brain slices were washed with PBS solution 3 times, each time for 30 min; after washing the residual first antibody incubation solution, the corresponding second antibody was added to the buffer solution, the volume ratio of the second antibody to the buffer solution was 1:500, and the second antibody incubation solution was obtained after mixing evenly. The mouse brain slices were transferred to the second antibody incubation solution, and placed on a shaker at 37°C and shaken at 50 rpm / min for 2 days, and then the brain slices were washed with PBS solution 3 times, each time for 30 min. The primary antibodies used in the process are as follows: glial fibrillary acidic protein antibody (anti-GFAP), neuron antibody (anti-NeuN), dopaminergic neuron antibody (anti-tyrosine hydroxylase) or endothelial cell antibody (anti-CD31); the secondary antibodies used in the process are as follows: goat anti-chicken 647 nano antibody (Alexa Fluor 647goat anti-chicken IgG (H&L)), donkey anti-mouse 488 nano antibody (Alexa Fluor 488donkey anti-mouse IgG (H&L)), donkey anti-rabbit 647 nano antibody (Alexa Fluor 647donkey anti-rabbit IgG (H&L)) or donkey anti-goat 555 nano antibody (Alexa Fluor 555donkey anti-goat IgG (H&L)).

[0070] 4) Dye staining group: Multiple mouse brain slices were placed in a 24-well plate, and 4',6-diamidino-2-phenylindole staining solution (DAPI), propidium iodide staining solution (PI), green fluorescent nucleic acid staining solution (SYTO), and thiazole red staining solution (TO-PRO-3) were added respectively. The plates were placed on a shaker at 37°C and incubated at 50 rpm / min for 2 days. The mouse brain slices were then washed with PBS solution 3 times, each time for 30 min.

[0071] 5) For the two groups of brain slices that have been stained, a clearing agent was added to each of them for clearing. After 5 minutes, the cleared mouse brain slices were sealed. A 150 μm gasket was used in the sealing step. The remaining steps were the same as in Example 2. After sealing, imaging was performed using a confocal microscope.

[0072] like Figure 7 (a) Figure 7 (b) Figure 7 (c) Figure 7 (d) Figure 7 (e), Figure 7 (f), Figure 7 (g) and Figure 7 As shown in (h), the imaging results of various fluorescent staining in the mouse brain slices in Example 4 are shown. It can be seen from the figure that the use of a transparent method that protects the fine structure of the tissue can be compatible with and imaged by various commonly used fluorescent labeling methods.

[0073] Embodiment 5:

[0074] The compatibility of common pathological staining methods with transparent methods that protect tissue fine structures and imaging are investigated as follows:

[0075] 1) Sample preparation: The biological tissue sampling procedure was the same as in Example 1. After obtaining the mouse brain tissue, it was embedded in paraffin and ultrathinly sliced ​​with a thickness of 10 μm. The brain slices were divided into two groups, one group was a control group that was not treated with a transparent reagent, and the other group was a test group that needed to be pre-soaked in a transparent reagent, with 4 slices in each group.

[0076] 2) 25 g of urea, 20 g of sorbitol, 20 g of iodixol, 25 ml of water and 20 ml of dimethyl sulfoxide were mixed evenly to obtain 100 ml of a transparent reagent that can retain fine structures and is fluorescence-friendly.

[0077] 3) For the test group, 1 ml of clearing agent was added to the mouse brain slices, and the slices were immersed and incubated for 5 min at a constant temperature of 30°C and an oscillation speed of 50 rpm / min, and then washed with PBS solution 3 times, each time for 5 min. For the control group, 1 ml of PBS solution was added to the mouse brain slices, and the slices were immersed and incubated for 5 min at a constant temperature of 30°C and an oscillation speed of 50 rpm / min, and then washed with PBS solution 3 times.

[0078] 4) HE staining, PAS staining, Nissl staining, and Masson staining were performed on the brain sections of the two groups as follows:

[0079] HE staining: Soak the mouse brain slices in xylene and shake gently for 30 minutes. Replace the xylene solution after 15 minutes. Then transfer the slices to a mixed solution of xylene and anhydrous ethanol with a volume ratio of 1:1 and shake gently for 2 minutes. Then transfer the slices to 100% ethanol and shake gently for 10 minutes. Replace the 100% ethanol after 5 minutes. Then transfer the slices to 80% ethanol and shake gently for 5 minutes. Next, transfer the slices to distilled water and shake gently for 5 minutes. Then transfer the slices to hematoxylin for staining for 5 minutes. Then wash the slices with water for 10 minutes. Then transfer the slices to Treat in 1% hydrochloric acid ethanol for 30 seconds; then wash the slices with water for 30 seconds; the next step is to wash with distilled water for 5 seconds; then transfer the slices to 0.5% eosin solution for staining for 1-3 minutes; then use distilled water to wash the slices for 30 seconds; then use 80% ethanol to wash the slices for 30 seconds; then soak the slices in 95% ethanol and shake gently for 2 minutes, and replace new 95% ethanol after 1 minute; then soak the slices in anhydrous ethanol and shake gently for 6 minutes, and replace new anhydrous ethanol after 3 minutes; then soak the slices in xylene and shake gently for 6 minutes, and replace new xylene after 3 minutes; finally use neutral gum to seal the slices.

[0080] PAS staining: Soak the mouse brain slices in xylene and shake gently for 40 minutes, replace the xylene solution after 20 minutes; then transfer the slices to 100% ethanol and shake gently for 20 minutes, replace the 100% ethanol after 10 minutes; then transfer the slices to 95% ethanol and shake gently for 5 minutes; then transfer the slices to 90% ethanol and shake gently for 5 minutes; then transfer the slices to 80% ethanol and shake gently for 5 minutes; then transfer the slices to 70% ethanol and shake gently for 5 minutes; next, transfer the slices to distilled water and shake gently for 5 minutes; then transfer the slices to periodic acid solution and shake gently. Shake for 10 minutes; then rinse with running water for 5 minutes; then transfer the slices to Schiff reagent for 10 minutes; then rinse with running water for 5 minutes; then transfer the slices to hematoxylin stain for 1 minute; then rinse with running water for 5 minutes; next, soak the slices in 95% ethanol and shake gently for 10 minutes, and replace new 95% ethanol after 5 minutes; then transfer the slices to 100% ethanol and shake gently for 10 minutes, and replace new 100% ethanol after 5 minutes; then transfer the slices to xylene and shake gently for 10 minutes, and replace new xylene after 5 minutes; finally, use neutral gum to seal the slices.

[0081] Nissl staining: Soak the mouse brain slices in xylene and shake gently for 30 minutes. Replace the xylene solution after 15 minutes. Then transfer the slices to 100% ethanol and shake gently for 10 minutes. Replace the 100% ethanol after 5 minutes. Then transfer the slices to 95% ethanol and shake gently for 5 minutes. Then transfer the slices to 90% ethanol and shake gently for 5 minutes. Then transfer the slices to 80% ethanol and shake gently for 5 minutes. Then transfer the slices to 70% ethanol and shake gently for 5 minutes. Next, transfer the slices to 50% ethanol and shake gently for 5 minutes. n; then rinse the slices with distilled water for 3 times, 5 minutes each time; stain the slices in 1% toluidine blue dye solution for 45 minutes at room temperature; after washing the dye with distilled water, differentiate with 70% alcohol for 2 minutes; next, soak the slices in 95% ethanol and shake gently for 10 minutes, and replace with new 95% ethanol after 5 minutes; then transfer the slices to 100% ethanol and shake gently for 10 minutes, and replace with new 100% ethanol after 5 minutes; then transfer the slices to xylene and shake gently for 10 minutes, and replace with new xylene after 5 minutes; finally, seal the slices with neutral gum.

[0082] Masson staining: Soak the mouse brain slices in xylene and shake gently for 40 minutes, replace the new xylene solution after 20 minutes; then transfer the slices to 100% ethanol and shake gently for 20 minutes, replace the new 100% ethanol after 10 minutes; then transfer the slices to 95% ethanol and shake for 5 minutes; then transfer the slices to 90% ethanol and shake gently for 5 minutes; then transfer the slices to 80% ethanol and shake gently for 5 minutes; then transfer the slices to 70% ethanol and shake gently for 5 minutes; next, transfer the slices to distilled water and shake gently for 5 minutes; use Weigert iron hematoxylin staining solution to stain the nucleus for 5 minutes; quickly rinse with distilled water for 30 seconds to remove Excess dye; then use acidic ethanol differentiation solution to differentiate for 5 seconds, and rinse again with distilled water; then place the slices in Masson blueing solution for 5 minutes; then use Ponceau fuchsin staining solution to stain for 10 minutes; then use aniline blue staining solution to stain for 2 minutes; next, place the slices in 1% glacial acetic acid for 2 minutes; next, soak the slices in 95% ethanol and shake gently for 10 minutes, and replace new 95% ethanol after 5 minutes; then transfer the slices to 100% ethanol and shake gently for 10 minutes, and replace new 100% ethanol after 5 minutes; then transfer the slices to xylene and shake gently for 10 minutes, and replace new xylene after 5 minutes; finally, use neutral gum to seal the slices.

[0083] 4) The stained brain slices are imaged using a white light scanner.

[0084] like Figure 8 (a) and Figure 8 As shown in (b), the imaging results of four pathological stainings in the mouse brain slices of the control group and the test group in Example 5 are shown. The images show that the transparent reagent treatment will not have a negative impact on the above four conventional pathological staining effects. It can be seen that this method is compatible with pathological staining and is expected to be used in pathological diagnosis and clinical medicine.

Claims

1. A transparent method to protect the delicate structure of tissues, It is characterized in that include: 1) Fixing and separating biological tissues and then slicing them to obtain biological tissue slices of a certain thickness; 2) After the biological tissue sections are labeled, they are immersed in a clearing agent prepared from a solvent, urea, sorbitol and iohexol for incubation; 3) sealing the incubated biological tissue sections; 4) The sealed biological tissue sections are transparently imaged without affecting the labeling and biological tissue structure.

2. The method for protecting the fine structure of tissue according to claim 1, Features: In the step 1), the thickness of the biological tissue slice ranges from 0 to 1000 μm.

3. The method for protecting the fine structure of tissue according to claim 1, Features: In the step 1), the biological tissue is brain, heart, lung tissue, spleen, liver or kidney; the biological tissue is derived from reptiles, birds or mammals.

4. The method for transparentizing tissue according to claim 1, Features: In the step 2), the mass volume ratio of urea to solvent is 350g-800g:1L, the mass volume ratio of sorbitol to solvent is 200g-500g:1L, and the mass volume ratio of iohexol to solvent is 200g-550g:1L.

5. The method for protecting the fine structure of tissue according to claim 1, Features: In the step 2), the solvent in the transparentizing agent is a mixed solution of dimethyl sulfoxide and water; the volume ratio of dimethyl sulfoxide to water is 1:0.5-1.

5.

6. The method for protecting the fine structure of tissue according to claim 1, Features: In the step 2), the biological tissue slices are specifically labeled before being immersed.

7. The method for transparentizing tissue according to claim 1, Features: In the step 2), when the biological tissue slices are immersed in the transparentizing agent for incubation, the temperature is kept at 20° C. to 40° C. and the shaking speed is kept at 20 rpm / min to 80 rpm / min.

8. The method for transparentizing tissue according to claim 1, Features: In the step 4), imaging is performed using an electron microscope or an optical microscope.

9. A transparentizing agent for transparent imaging, Features: The transparentizing agent for transparent imaging is prepared by the transparentizing method described in any one of claims 1-8.

10. Use of the transparentizing agent for transparent imaging according to claim 9, Features: Applications described include use in two-photon and confocal clearing imaging.